YH25448, a 3rd generation EGFR-TKI, in patients with EGFR-TKI-resistant NSCLC: Phase I/II study results.

Cho, BC; Han, JY; Kim, SW; Lee, KH; Kim, DW; Lee, YG

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索